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macrophages, although they did not influence the expression of CD80 and 
CD86 co-stimulatory molecules on M1 macrophages. 
Conclusions: We characterized exosomes isolated from SF of patients 
with gonarthrosis and demonstrated that they are functionally active in 
their ability to stimulate the release of proinflammatory cytokines and 
MMPs from M1 macrophages, suggesting that they may play a role in 
disease progression. 
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Background: Alzheimer’s disease (AD) is a common and complex age-
related neurological disorder worldwide. Despite the advancements in 
understanding the genetic, molecular, and environmental factors of AD, 
there are no effective treatments to stop or reverse AD related symptoms. 
Early diagnosis of AD remains a big challenge as it takes a decade or 
more before the illness appears. Furthermore, post-mortem verification is 
often required. Therefore, there is an urgent need of biomarkers that can 
effectively detect early stage AD. MicroRNA (miRNA) is a class of non-
coding RNA (∼22-nt long) that regulates gene expression post-
transcriptionally. Accumulating evidence suggests that miRNA plays a 
crucial role in neural development and differentiation. About 70% of the 
currently identified miRNAs are reported to be expressed in the brain. In 
this study, we systematically evaluated the available literature to 
understand the role of miRNA in AD pathogenesis. 
Methods: The major biomedical databases were searched systematically 
to identify miRNA expression signatures in AD. Relevant articles were 
extracted by online searching using a combination of the following MeSH 
terms: microRNA or miRNA or miR and Alzheimer’s Disease. 
Results: We found that a number of miRNAs are deregulated in AD 
patients compared to the normal age-matched controls. 
Conclusions: Our data suggest that miRNA signatures may have 
potential to be considered as a screening tool as well as a therapeutic 
target for AD. 
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Background: Exosomes circulating in biological fluids largely mirror the 
molecular profile of the originating cells. Given the non-invasive nature of 
urine collection,analysis of urinary exosome content could be useful in the 
identification of new biomarkers in prostate cancer. This pilot study 
evaluated the expression of known prostate cancer genes (PSA, PCA3 
and PSMA) as potential exosomes biomarkers. 
Methods: mRNA and protein contents (PSMA, CD63, CD9) of urinary 
exosomes collected from 20 pre-and 14 post-radical prostatectomy 
patients and 8 healthy age-matched men were examined. The correct 
isolation of exosomes was confirmed by dynamic light-scattering, 
transmission electron microscopy, and Western-blot analysis. Western-
blot analysis, RT-PCR and nested RT-PCR were used to evaluate the 
expression of PSMA, PSA and PCA3 content, respectively. 
Results: Expression of PSA in urinary exosomes displayed 70% 
sensitivity, 62.5% specificity and an overall accuracy of 67.8% in 
identifying prostate cancer. PCA3 sensitivity, specificity and overall 
accuracy were 55%, 87.5%, and 64.3%, respectively. PSMA sensitivity, 
specificity, and overall accuracy were 76.5%, 57.1%, and 70.8%, 
respectively. These values were 85%, 87.5%, and 85.7%, respectively, 
when all three genes were simultaneously detected in extracted 
exosomes. Moreover, expression of PSA, PCA3, and PSMA were no 
longer detectable in a significant fraction of patients after surgery 
(p=0.0005, p= 0.032, p=0.0002, respectively). 
Conclusions: This pilot study suggests that urinary exosomes could be 
used as non-invasive  biomarkers for prostate cancer detection, with an 
overall accuracy comparable to the traditional PSA. Levels of urinary 
exosomes are strongly related to surgery and could be adopted into post-
operative surveillance. 
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Background: Liquid biopsy offers a promising alternative for tumor 
characterization and disease monitoring. Exosomes shed by cancer cells 
are attractive for their content stability in biological fluids and ability to 
mirror the molecular profile of the originating cells. This study aimed to 
evaluate the possibility to identify exosomes-associated DNA from colon 
cancer cell lines and from plasma of colorectal cancer patients (CRC pts) 
and to analyze their potential use in clinical settings. 
Methods: Exosomes were isolated by ultracentrifugation from plasma of 
10 CRC pts and from the supernatant of human colon cancer cells and 
were characterized. Mutation analysis of KRAS in DNA extracted from 
exosomes was evaluated by real-time PCR and confirmed by PCR-RFLP. 
Results: We set  up the protocols  for DNA isolation from  exosomes and 
for the analysis of KRAS G12V mutation by HRM analysis. KRAS 
mutation was confirmed by PCR-RFLP  using MvaI endonuclease 
digestion. The analysis of exosomes DNA extracted from supernatant of 
colorectal cancer cells or from plasma of CRC pts confirmed that the 
isolated DNA displays the same mutational status of DNA extracted from 
cancer cell lines or from the corresponding primary tumors, respectively. 
Conclusions: This pilot study suggests that DNA extracted from 
exosomes can be useful for the analysis of KRAS mutational status in 
colorectal cancer patients. We are currently evaluating the possibility to 
detect mutations in other genes (i.e., BRAF). Further studies are 
warranted to evaluate the suitability of exosome extracted DNA as a non-
invasive diagnostic, predictive, and surveillance biomarker in colon cancer 
patients. 
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Background: Cerebral small vessel disease (CSVD), detected as white 
matter hyperintensities (WMH) on brain MRI, could be a distinct 
pathological entity within cerebrovascular diseases. However, the several 
pathogenic hypotheses so far proposed were based on very 
heterogeneous clinical settings. Endothelial dysfunction seems to play a 
pivotal role but more studies are needed to clarify it. 
Methods: This is a pilot-case control study of young patients with CSVD. 
WMH severity was graded using the Fazekas score. Clinical history of 
patients and controls were negative for vascular and heart disease, 
classical vascular risk factors, autoimmune disorders, and coagulopathies. 
None of the patients reported family history of cerebrovascular disease. 
Blood samples were consecutively collected in the early morning and 
tested for inflammatory, endothelial, and prothrombotic markers. 
Results: 14 patients and 12 age- and sex-matched controls were 
recruited (mean age 52.6±5.9 yrs). Baseline clinical characteristics did not 
differ between the two groups. The mean Fazekas score in patients was 
2.9±0.86. Compared to controls, patients did not display higher levels of 
common inflammatory markers (C-reactive protein, fibrinogen, IL-6, IL10) 
and plasma prothrombotic factors (PAI, vWF, tPA, PAF-AH, 
homocysteine). In contrast, the levels of asymmetric dimethylarginine 
(ADMA), an endogenous inhibitor of nitric oxide, were significantly 
increased in patients compared to controls (122.2±33.7 µmol/l versus 
93.4±32.8 µmol/l; p=0.04). 
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Conclusions: Our pilot study suggests that ADMA, a known marker of 
endothelial dysfunction, may represent a new biomarker to identify 
asymptomatic CSVD, indicating the pathway of nitric oxide may be 
involved in endothelial dysfunction in this clinical setting. 
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Background: Platelets represent a major player in the process of 
intravascular thrombus formation. Despite significant advancements in 
antithrombotic therapy, current strategies still fail to prevent thrombotic 
coronary events in a substantial number of patients, indicating that the 
complex mechanisms modulating platelet response during activation are 
not fully elucidated. The evidence that platelets are capable of de novo 
protein synthesis has raised the issue of whether and how these resident 
mRNAs are regulated in circulating platelets. Among the various 
mechanisms potentially involved, mRNA splicing may be potentially 
relevant. 
Methods: Purified platelet-rich plasma from healthy volunteers were 
collected and in vitro activated with collagen or thrombin receptor 
activating peptide. Transcriptome analysis by RNA-Seq and in silico intron 
retention analysis were applied to search for splicing events affected by 
platelet activation. HiRIEF LC-MS allowed platelet proteome 
characterization at deep coverage to investigate a possible correlation 
between splicing events and protein levels. 
Results: Extensive computational analysis following RNA-Seq revealed 
several splicing events occurring in activated platelets. By applying 
unbiased proteogenomics, we correlated intron retention events in 
quiescent platelets to exon-exon junctions frequency after activation. In 
this way we identified a set of transcripts presenting reduced intron 
retention and high peptide representation at exon-exon junctions in 
activated vs resting platelets. 
Conclusions: The observed results indicate that pre-mRNA maturation of 
platelet-specific transcripts could be monitored and used as marker of 
platelet activation in acute coronary syndromes.    
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Background: The probiotic Lactobacillus reuteri is effective against 
infantile colic, alleviation of eczema and Helicobacter pylori colonization. 
L.reuteri develops biofilm in vitro, producing factors that give health benefit 
to the host although the mechanism by which commensal bacteria 
communicate with the host remains unclear. The purpose of this study 
was to detect and characterize membrane vesicles (MVs), bilayer 
structures containing several molecules generated by bacteria, produced 
by L.reuteri  DSM 17938. 
Methods: The structure of MVs was evaluated by transmission and 
scanning electron microscope analysis. MVs were subsequently isolated 
by biofilm (bMVs) and planktonic (pMVs) phenotypes by 
ultracentrifugation and physicochemically characterized by dynamic light 
scattering (DLS) analysis. An enzymatic treatment was performed to 
determine MVs composition. eDNA was detected and quantified using the 
Quant-iTTMPicoGreendsDNA assay and NanoDropUV-VIS 
spectrophotometer. Proteins associated with MVs were extracted and 
quantified by BCA assay. 
Results: PicoGreen showed that eDNA was associated with MVs and that 
its concentration is higher in bMVs than in pMVs,  although an inverse 
correlation was found in the protein concentration, suggesting a different 
role of MVs in the two phenotypes. The enzymatic treatment showed that 
lipids and proteins represent the main structural components of MVs. The 
DLS analysis demonstrated that L.reuteri generates MVs with sizes in the 
nanometer range and a broad size distribution. 
Conclusions: L.reuteri produces MVs whose main components are lipids 
and proteins; eDNA is also associated to MVs. The biological activity and 
composition of MVs may represent the starting point for future applications 
in the development of vesicles-based therapeutic systems. 
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Background: Pancreatic cancer is one of the most lethal malignancies 
and somatic mutations of protocadherins have been identified. Some of 
them were recently identified as tumor-suppressor genes; in particular, 
PCDH10 is a functional tumor suppressor gene frequently silenced by 
methylation in multiple carcinomas. Our goal is to evaluate the prognostic 
significance of protocadherin methylation in pancreatic adenocarcinoma 
so we studied methylation in primary pancreatic cancers. Functional 
assays with a PCDH10 re-expressing pancreatic cancer cell line is in 
progress to characterize its biological effects in pancreatic tumorigenicity. 
Methods: 38 ductal pancreatic adenocarcinomas were recruited in “Casa 
sollievo della sofferenza” Hospital, S.Giovanni Rotondo. DNA was 
extracted from tumor tissue and treated with bisulfite solution. COBRA 
analysis and bisulfite genomic sequencing were used to determine the 
presence of methylated CpG in the promoter regions. A functional assay 
using AspC-1 and Capan-2 pancreatic cancer cell lines transfected with 
full length PCDH10 will assess the effect of PCDH10 on pancreatic cancer 
cell growth. 
Results: Cases were studied for PCDHAC2, PCDHGC5 and PCDH10 
methylation status and immunohistochemistry (IHC). Results showed no 
PCDHAC2 methylation pattern and ubiquitous methylation of PCDHGC5 
in all cases analysed. PCDH10 analysis showed a partial methylation 
pattern in 9/18 and no methylation in 9/18 cases analysed. IHC analysis 
detected PCDHAC2 expression in 6% of cases analysed and PCDHGC5 
in 30%. IHC of PCDH10 is in progress. 
Conclusions: The identification of aberrantly hypermethylated and 
silenced genes will have diagnostic, prognostic, and therapeutic 
applications. PCDH10 may be a potential target gene for cancer therapy. 
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Background: Primary pleural and pulmonary synovial sarcomas (PPSSs) 
are very rare and aggressive neoplasms that affect adults. The oncologic 
characteristics, treatment, and prognosis for PPSSs are not well defined 
because of a paucity of data. Dysregulation of Wnt/β-catenin and EGFR 
pathways leads to tumorigenesis with poor prognosis. We investigated the 
involvement of Wnt/ β-catenin and EGFR signaling in PPSSs. 
